TGFB1 and systemic lupus erythematosus: For example, anti-CD4 and anti-CD2-coated poly(lactic-co-glycolic) acid (PLGA) nanoparticles loaded with IL-2 and TGFβ expanded Treg cells in vitro and in vivo in the BDF1 lupus pre-clinical model (136).